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Disorders of the Nervous System
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Abstract
Compromise in inspiratory breathing following cervical spinal cord injury (SCI) is caused by damage to descending bulbospinal axons originating in the rostral ventral respiratory group (rVRG) and consequent denervation and
silencing of phrenic motor neurons (PhMNs) that directly control diaphragm activation. In a rat model of
high-cervical hemisection SCI, we performed systemic administration of an antagonist peptide directed against
phosphatase and tensin homolog (PTEN), a central inhibitor of neuron-intrinsic axon growth potential. PTEN
antagonist peptide (PAP4) robustly restored diaphragm function, as determined with electromyography (EMG)
recordings in living SCI animals. PAP4 promoted substantial, long-distance regeneration of injured rVRG axons
through the lesion and back toward PhMNs located throughout the C3–C5 spinal cord. These regrowing rVRG
axons also formed putative excitatory synaptic connections with PhMNs, demonstrating reconnection of rVRGPhMN-diaphragm circuitry. Lastly, re-lesion through the hemisection site completely ablated functional recovery
induced by PAP4. Collectively, our findings demonstrate that axon regeneration in response to systemic PAP4
administration promoted recovery of diaphragmatic respiratory function after cervical SCI.
Key words: cervical; diaphragm; phrenic; plasticity; PTEN; sprouting

Significance Statement
Using non-invasive and only transient systemic delivery of an antagonist peptide that targets phosphatase
and tensin homolog (PTEN), we promoted significant regeneration of bulbospinal respiratory axons into and
through a large lesion site in a rat model of cervical spinal cord injury (SCI), as well as growth of these axons
back into the intact distal spinal cord for several spinal segments. We also found that these regenerating
axons synaptically reconnected with their appropriate postsynaptic respiratory motor neuron targets,
resulting in reconnection of the damaged neural circuit. Furthermore, by showing that re-lesion of regenerating axons resulted in complete loss of PTEN peptide-induced diaphragm recovery, we demonstrate that
long-distance axon regeneration can drive recovery of respiratory function following cervical SCI.
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Figure 1. Schematic of the rVRG-PhMN-diaphragm circuit. Schematic of intact (A), ipsilateral regeneration of ablated rVRG fibers (B),
and contralateral rVRG fiber sprouting (C). Blue lines represent descending rVRG axons and red dotted lines represent regrowing
axons. D, Experimental timeline: C2 hemisection was performed on all animals, and from days 3 to 24 after injury, animals were
treated with twice-daily subcutaneous injections of either DMSO or PAP4. Two weeks following injury, animals received either
ipsilateral or contralateral brainstem injections of AAV2-mCherry. Four days before killing, CMAP recordings were taken for each
animal and CTB injections into the ipsilateral hemidiaphragm were performed. At eight weeks after injury, EMG recordings were taken,
and then animals were killed to collect brain and spinal cord tissue samples.

Introduction
Traumatic spinal cord injury (SCI) produces many
debilitating outcomes, including respiratory compromise (Lane et al., 2008a). A majority of human SCI
cases occur in the cervical spinal cord, resulting in
persistent diaphragm dysfunction that is associated
with mortality, a host of morbidities such as respiratory
infections, and greatly reduced quality of life (Warren
and Alilain, 2014; Warren et al., 2014). Diaphragm is
directly controlled by phrenic motor neurons (PhMNs)
located at cervical levels C3–C5 (Lane et al., 2009).
PhMNs are mono-synaptically activated by supraspinal
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brainstem neurons located in the rostral ventral respiratory group (rVRG; Fig. 1A; Dobbins and Feldman,
1994). Cervical SCI results in axotomy of descending
rVRG fibers, denervation and consequent silencing of
spared ipsilateral PhMNs, and partial-to-complete
hemidiaphragm paralysis (Fig. 1B; Urban et al., 2018).
Restoration of rVRG-PhMN-diaphragm circuitry therefore represents a critically important therapeutic target
for individuals affected by SCI.
Promoting the combination of robust regeneration of
damaged rVRG axons and synaptic reconnection of these
growing axons with their PhMN targets is a major goal for
addressing diaphragmatic respiratory compromise following cervical SCI. However, various inhibitory mechanisms limit/prevent robust axonal growth and ultimately
the synaptic reconnectivity that will mediate functional
restoration after CNS injury. These include (1) neuronalintrinsic factors that limit the ability of both injured and
spared CNS neurons to mount an axon growth response
(Luo and Park, 2012) and (2) environmental impediments
to axon growth such as an acellular cystic cavity, the
molecular barrier presented by the glial scar, myelinassociated inhibitory molecules, and repulsive developmental axon guidance molecules that continue to be
expressed in the adult CNS (Bradbury et al., 2002; Giger
et al., 2010).
eNeuro.org
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Blocking environmental sources of regenerative inhibition in SCI models results in only limited axonal regrowth,
suggesting the importance of modulating intrinsic growth
capacity of neurons (Huebner and Strittmatter, 2009). The
phosphatase and tensin homolog (PTEN)-mechanistic
target of rapamycin (mTOR) axis is a key pathway that is
involved in the developmental down-regulation of axon
growth capacity (Park et al., 2010). Experimentally modulating this signaling system has been shown to successfully promote axon regrowth in SCI animal models,
including plasticity of patient-relevant neuronal populations such as corticospinal tract axons (Park et al., 2010;
Luo and Park, 2012; Liu et al., 2015). The axon growth
response to molecules such as neurotrophic factors occurs in part via receptor-mediated activation of Akt. This
results in downstream activation of mTOR, thereby initiating a pro-growth state by regulating mechanisms such
as, for example, gene transcription and protein translation
in the neuronal soma and cytoskeletal dynamics in axons
(although additional processes likely are also involved;
Park et al., 2010; Kanno et al., 2012). PTEN is a phosphatase that prevents Akt activation by converting PIP3 to
PIP2. Inducible genetic knockout of PTEN (Park et al.,
2008; Liu et al., 2010; Willenberg et al., 2016) or viral
vector-based shRNA knockdown (Zukor et al., 2013; Lewandowski and Steward, 2014) increases CNS axonal
growth after injury, while mTOR inhibition blocks the progrowth effects of genetic PTEN deletion, demonstrating
that PTEN puts a brake on the neuron’s ability to signal
through mTOR.
In the current work, we tested systemic administration
of a PTEN antagonist peptide (PAP) in a rat model of
high-cervical (level C2) SCI (Urban et al., 2018), a novel
approach to promote plasticity of rVRG neurons and restoration of rVRG-PhMN-diaphragm circuitry. We previously developed a number of PAPs directed against
various regions of the PTEN protein (Ohtake et al., 2014).
These peptides bind directly to and inhibit the activity of
PTEN. The PAP used in the current study is a 30 amino
acid peptide (including the TAT sequence for facilitating
entry into cells) that targets the C-terminal tail of PTEN.
We chose to use this particular PAP (termed PAP4) because it results in the most robust axon growth in the
thoracic dorsal funiculotomy SCI model. Specifically, we
have previously shown that systemic PAP4 delivery promotes plasticity of injured corticospinal tract axons, enhances serotonergic fiber growth and results in partial
recovery of hindlimb motor function (Ohtake et al., 2014).
Importantly, PAP4 cross the blood-brain barrier and enters CNS parenchyma after systemic injection.
PAP4 is a powerful tool both experimentally and therapeutically for manipulating axon growth capacity after
SCI. PAP4 has therapeutic potential given that it can be
delivered in a non-invasive, systemic manner and for
defined temporal duration (Ohtake et al., 2014). PAP4 also
allows us to examine the effects of modulating PTEN
function, and more generally neuronal-intrinsic growth
inhibition, on rVRG axon growth and respiratory recovery
after SCI. Lastly, PAP4 provides an in vivo experimental
tool to study the contribution of defined modes of axonal
September/October 2019, 6(5) ENEURO.0096-19.2019
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growth and rVRG-PMN circuit reconnectivity to recovery
of function following SCI (i.e., regeneration of injured axons originating in the ipsilateral rVRG vs sprouting of
spared fibers originating in the contralateral rVRG).
In this study, we show that systemic administration of
PAP4 to cervical SCI rats promotes robust, long-distance
regeneration of injured bulbospinal rVRG axons and synaptic reconnection of these regrowing fibers with their
PhMN targets, which was associated with significant recovery of diaphragmatic respiratory function.

Materials and Methods
Animal model
Female Sprague Dawley rats weighing 250 –300 g were
purchased from Taconic Farms. All rats were housed
three animals per cage in temperature, humidity and light
controlled environments with ad libitum access to food
and water. Experimental procedures were approved by
the Thomas Jefferson University IACUC and conducted in
compliance with Animal Research: Reporting of In Vivo
Experiments (ARRIVE) guidelines and the Society for Neuroscience’s Policies on the Use of Animals and Humans in
Neuroscience Research.
Postoperative care
Following survival surgeries, muscle layers were sutured with 4 – 0 silk sutures (Covidien) and the skin was
closed with surgical staples (Braintree Scientific). The
surface of the skin was treated with a topical iodine
solution. Immediately following the procedure, rats were
treated with 5-ml subcutaneous injections of lactated
Ringer’s solution (Hospira), buprenorphine hydrochloride
(0.05 mg/kg; Hospira) and cefazolin (6 mg; Hospira). Rats
were then placed in a clean cage on a surgical heating
pad set to 37°C (Gaymar). At 12 and 24 h after surgery,
each rat was given an additional dose of buprenorphine
hydrochloride (0.05 mg/kg) and 5 ml of lactated Ringer’s
solution and monitored for pain/distress.
C2 hemisection SCI
Rats were anesthetized with an intraperitoneal injection
of ketamine HCl (95.0 mg/kg; Vedco), xylazine (10.0 mg/
kg; Lloyd Laboratories), and acepromazine (0.075 mg/kg;
Phoenix Pharm Inc). Using a #11 surgical blade (Electron
Microscopy Sciences), a one-inch midline incision was
made on the dorsal surface of skin and muscle to expose
the dorsal surface of the C2 and C3 vertebrae. A laminectomy was performed above C2 to expose the spinal cord
using rongeurs (Fine Science Tools). A hemisection was
performed just caudal to the C2 root with a dissecting
knife (Fine Science Tools; Urban et al., 2018). To ensure a
complete hemisection, a 30-gauge needle (BD Biosciences) was passed through the injury several times.
rVRG injection
Rats were anesthetized with a mixture of ketamine/
xylazine/acepromazine, as described above. Using a #11
surgical blade, a half-inch incision was made on the dorsal surface of the skin at the occipital bone and superficial
muscles were separated with surgical scissors (Fine Science Tools) and a retractor (Fine Science Tools), exposing
eNeuro.org
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the occipital bone and C1 vertebrae. Rongeurs were used
to remove the ligament between the occipital bone and
the C1 vertebrae, followed by removal of the caudal portion of the occipital bone to reveal the obex. The animals
were then placed on a stereotaxic frame (Kopf Instruments). Using the obex as a starting point, the rVRG was
located by the following coordinates: 2.0 mm lateral, 1.0
mm rostral, and 2.6 mm ventral. An UltraMicroPump
(World Precision Instruments) injection system was used
to inject 0.3 l of total volume of AAV2-mCherry with a
microsyringe (Hamilton) attached to a Micro4 Microsyringe Pump Controller (World Precision Instruments; Urban et al., 2018). Immediately following injection, the
needle was left in place for 5 min before being slowly
removed from the medulla.
Diaphragm injection
Rats were anesthetized with a mixture of ketamine/
xylazine/acepromazine. A laparotomy was performed
starting from the xyphoid process and cutting laterally just
below the rib cage to expose the right hemidiaphragm.
Once exposed, cholera toxin subunit B recombinant, Alexa Fluor 647 conjugate (Life Technologies) was injected
into the ventral, medial and dorsal portions of the hemidiaphragm (5 l injected per site), specifically targeting
the endplate band (Li et al., 2015b).
Electromyography (EMG) recordings
Once the animals were deeply anesthetized with ketamine/xylazine/acepromazine, a laparotomy was performed to expose hemidiaphragm. Bipolar electrodes
spaced 3 mm apart were placed for recording in three
separate subregions of the hemidiaphragm: dorsal, medial and ventral. Recordings during normal eupnic breathing were averaged over a continuous 60-s time frame for
each animal, and peak amplitude, burst duration and
frequency were taken (Nicaise et al., 2012, 2013). Every
inspiratory burst over these 60 continuous seconds was
included in the analysis. Using LabChart 7 software [ADInstruments; Research Resource Identification Initiative
RRID: SCR_001620], the EMG signal was amplified and
filtered through a bandpass filter (50 –3000 Hz).
Compound muscle action potential (CMAP)
recordings
Rats were anesthetized with isoflurane (Piramal Healthcare) at a concentration of 3.0 –3.5% diluted in oxygen.
Animals were placed supine, and the region just below the
rib cage was shaved and cleaned with 70% ethanol.
Phrenic nerve conduction studies were performed with
stimulation of the phrenic nerve via needle electrodes
transcutaneously inserted into the neck of the rat in proximity to the passage of the phrenic nerve (Lepore et al.,
2008, 2010). A reference electrode was placed on the
shaved surface of the right costal region. The phrenic
nerve was stimulated with a single burst at 6 mV (amplitude) for a 0.5-ms duration. Each animal was stimulated
between 10 and 20 times to ensure reproducibility, and
recordings were averaged for analysis. ADI Powerlab8/30
stimulator and BioAMP amplifier (ADInstruments) were
used for both stimulation and recording, and Scope 3.5.6
September/October 2019, 6(5) ENEURO.0096-19.2019
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software (ADInstruments; RRID: SCR_001620) was used
for subsequent data analysis. Following recordings, animals were immediately euthanized with a dose of Euthasol, and tissue was collected (as described below).
Spinal cord and brainstem dissection
Animals were euthanized with Euthasol. After the right
hemidiaphragm was excised, the animal was exsanguinated by cutting the right atrium. Next, the animal was
transcardially perfused with 0.9% saline solution (Fisher
Scientific), followed by 4% paraformaldehyde (Electron
Microscopy Sciences) to fix the tissue. Following perfusion, the spinal cord and brain were excised with rongeurs
(Fine Science Tools) and kept in a 4% paraformaldehyde
solution overnight at 4°C, washed with 0.1 M phosphate
buffer [sodium phosphate dibasic heptahydrate (SigmaAldrich) and sodium monobasic monohydrate (SigmaAldrich)], and placed in 30% sucrose (Sigma-Aldrich).
Samples were then submerged in an embedding mold
(Polysciences, Inc) and covered with tissue freezing medium (General Data). Samples were then flash frozen in
2-methylbutane (Fisher Scientific) chilled in dry ice. Tissue
was sectioned on a cryostat (Thermo Scientific). Brainstem (transverse) and spinal cord (sagittal) sections were
cut at 30 m, placed on glass slides (Fisher Scientific),
dried overnight, and stored at –20°C for histologic analysis.
Immunohistochemistry
Before immunostaining, tissue sections were dried for 1
h at room temperature. Antigen retrieval was performed
using R&D Systems Protocol (R&D Systems). Immediately
after antigen retrieval, a hydrophobic pen was used to
surround the tissue sections (Newcomer Supply). Slides
were blocked/permeabilized for 1 h at room temperature
with a solution of 5% normal horse serum (Vector Laboratories), 0.2% Triton X-100 (Amresco), diluted in PBS
(primary and secondary antibodies were diluted in this solution as well). Slides were then treated with primary antibody overnight at 4°C with the following antibodies: neuronal marker anti-NeuN at 1:200 (EMD-Millipore; RRID:
AB_2298772), astrocyte marker anti-GFAP at 1:400 (Dako;
RRID: AB_10013482), oligodendrocyte lineage marker antiOlig-2 at 1:200 (EMD-Millipore; RRID: AB_2299035), antisynaptophysin antibody at 1:250 (Abcam, Cambridge, MA;
RRID:AB_2198854), anti-5HT antibody at 1:500 (Immunostar; RRID:AB_572263), anti-phospho-S6 ribosomal protein
(Ser235/236) at 1:50 (Cell Signaling Technology; RRID:
AB_331679), anti-wheat germ agglutinin (WGA) at 1:50
(Vector Laboratories; RRID:AB_2315608), anti-VGLUT2 at
1:250 (EMD-Millipore; RRID:AB_2187552), anti-DsRed at
1:500 (Clontech Laboratories, Inc.; RRID:AB_10013483),
anti-CTB at 1:10,000 (List Biological Laboratories). On the
following morning, samples were washed 3⫻ in PBS, and
secondary antibody solutions were added for 1 h at room
temperature: donkey anti-rabbit IgG H&L (Alexa Fluor 647)
at 1:200 (Abcam), donkey anti-mouse IgG H&L (Alexa
Fluor 488) at 1:200 (Abcam), rhodamine (TRITC) AffiniPure
donkey anti-goat IgG (H ⫹ L) at 1:200 (Jackson ImmunoResearch). Following secondary antibody treatment,
samples were washed in PBS, and two to three drops of
eNeuro.org
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FluorSave reagent (Calbiochem) were added to tissue
sections, then slides were coverslipped (Fisher Scientific).
Slides were stored at 4°C.
Spinal cord histology
Tissue sections were dried at room temperature for 2 h.
Slides were then placed in 3-min baths of xylene, 100%
ethanol, 95% ethanol, 70% ethanol, and dH2O. Slides
were next placed in an eriochrome solution (0.16% eriochrome cyanine, 0.4% sulfuric acid, 0.4% ferric chloride
in dH2O) for 14 min, washed with tap water, placed in a
developing solution (0.3% ammonium hydroxide in dH2O)
for 5 min, washed with dH2O, and then placed into a
cresyl violet solution (0.4% cresyl violet, 6% 1 M sodium
acetate, and 34% 1 M acetic acid) for 18 min. Finally,
slides were placed in baths of dH2O, 70% ethanol, 95%
ethanol, 100% ethanol, and xylene. Slides were then
mounted with poly-mount xylene (Polysciences), and
cover slips were added. Slides were then kept at room
temperature for analysis.
pS6K70 immunofluorescence quantification
Brainstem sections were immunostained with antiphospho-S6 ribosomal protein (Ser235/236), followed by
donkey anti-mouse IgG H&L (Alexa Fluor 488) at 1:200
(Abcam). Individual mCherry⫹ rVRG neurons were traced
manually in ImageJ/Fiji software (RRID:SCR_003070), using images captured via 20x objective on a Zeiss Axio M2
Imager (Carl Zeiss Inc.; Urban et al., 2018). Mean intensity
per mCherry⫹ cell was measured using ImageJ/Fiji software. Average background intensity values were subtracted from individual neurons to obtain each intensity
value. Average neuronal intensities were recorded and
resulting values were quantified using three tissue sections per animal, and three animals were used per group.
For pS6K quantification, measurements of individual neurons were not averaged within an animal to produce a
single value for a given animal. We choose to perform the
analysis in this manner as we observed significant
neuron-to-neuron variability in pS6K levels within an animal. Obtaining a single mean value for the entire animal
does not reflect the shift we saw in individual neurons
across the entire population within an animal. Importantly,
changes in this intracellular signaling can have significant
effects on functional outcome even if only a subset of
these rVRG neurons have alterations in PTEN signaling
and consequent effects on axonal growth capacity.
rVRG axon regeneration quantification
To detect mCherry anterograde tracer expression,
30-m sagittal sections of spinal cord tissue were imaged
with a Zeiss Axio M2 Imager (Carl Zeiss Inc.). The highmagnification images were then optically “stitched” using
MetaMorph software (Molecular Devices; RRID:SCR_002368)
to generate a complete image of the cervical spinal cord.
The stitched images were rostral-caudally binned in
100-m segments using the rostral border of the injury
and rostral intact spinal cord as the starting point (Urban
et al., 2018). All mCherry-labeled axons were counted;
axons that traversed through more than one bin were
counted in all bins that they traversed.
September/October 2019, 6(5) ENEURO.0096-19.2019
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Analysis of putative synaptic contacts between rVRG
axons and PhMNs
To assess putative excitatory synaptic connections
between presynaptic mCherry⫹/VGLUT2⫹ rVRG axon
terminals and postsynaptic CTB⫹ PhMNs, we immunostained sagittal sections with antibodies against DsRed,
CTB, and VGLUT2 (Urban et al., 2018). For quantification of
connections at level C3 ipsilateral to lesion, we considered
contacts in which the mCherry⫹/VGLUT2⫹ terminal was
located within 2.5 m of the surface of the CTB⫹ PhMN cell
body in single-z confocal images, based on previous work
(Kinkead et al., 1998; Issa et al., 2010). PhMN membrane
surface area was not considered in this analysis.
Quantification of rVRG axon sprouting
Here, 30-m sagittal tissue sections from cervical spinal cords of animals injected with AAV2-mCherry into the
contralateral rVRG were immunostained with anti-DsRed
antibody (1:200). mCherry-labeled axon profiles were
counted in the ventral horn ipsilateral to the injury at C3,
C4, and C5 regions using a standard area size of analysis
for every section, at each spinal cord level and in all
animals. Five sections of tissue were analyzed per animal
and 4 animals per group were quantified. Results are
expressed mean ⫾ SEM.
5-HT analysis
For quantitative analysis of 5-HT immunostaining, we
used the same image acquisition parameters for all samples, including excitation light intensity, camera settings
and exposure time. In sagittal sections, we quantified
number of 5-HT axon profiles, total 5-HT axonal length
and integrated intensity of 5-HT immunolabeling within
the CTB-labeled PhMN pool ipsilateral to the injury at
C3–C5 (Ghosh et al., 2018). To assess the number of
putative synaptic connections between presynaptic
5-HT⫹/synaptophysin⫹ serotonergic axon terminals and
postsynaptic CTB⫹ PhMNs, we immunostained sagittal
sections with antibodies against 5-HT, CTB and synaptophysin. For quantification at levels C3, C4 and C5 ipsilateral to the lesion, we considered contacts in which the
5-HT⫹/synaptophysin⫹ terminal was located within 2.5
m of the surface of the CTB⫹ PhMN in single-z confocal
images (Ghosh et al., 2018).
Diaphragm dissection
Animals were euthanized with Euthasol (Virbac AH Inc.)
and then placed in a supine position. Two incisions were
made into the skin and underlying muscle to expose the
right hemidiaphragm. The right hemidiaphragm was
excised using spring scissors (Fine Science Tools), stretched
flat and pinned down on silicon-coated 10-cm dishes, and
washed with PBS (Gibco). Diaphragms were then fixed for 20
min in 4% paraformaldehyde (Electron Microscopy Sciences).
After washing in PBS, superficial fascia was carefully removed
from the surface of the diaphragm with Dumont #5 Forceps
(Fine Science Tools). Diaphragms were then stained for neuromuscular junction (NMJ) markers (see NMJ analysis).
eNeuro.org
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Diaphragm whole-mount histology
Fresh hemidiaphragm muscle was dissected from each
animal for whole-mount immunohistochemistry, as described previously (Wright and Son, 2007; Wright et al.,
2007, 2014). Diaphragms were rinsed in PBS and then
incubated in 0.1 M glycine for 30 min. Following glycine
incubation, ␣-bungarotoxin conjugated to Alexa Fluor 555
at 1:200 (Life Technologies) was used to label postsynaptic nicotinic acetylcholine receptors. Ice-cold methanol
was then added to the diaphragms for 5 min, and then
diaphragms were blocked for 1 h at room temperature in
a solution of 2% bovine serum albumin and 0.2% Triton
X-100 diluted in PBS (this solution was used for both
primary and secondary antibody dilutions). Primary antibodies were added overnight at 4°C: presynaptic vesicle
marker anti-SV2 at 1:10 (Developmental Studies Hybridoma Bank; RRID: AB_2315387), neurofilament marker
anti-SMI-312 at 1:1000 (Covance; RRID:AB_2314906).
The diaphragms were then washed and secondary antibody
solution was added for 1 h at room temperature: FITC antimouse IgG secondary (Jackson ImmunoResearch; 1:100). Diaphragms were mounted with Vectashield mounting medium
(Vector Laboratories), coverslips were added, and slides were
stored at –20°C.
NMJ analysis
Labeled muscles were analyzed for the percentage of
NMJs that were intact, partially denervated, or completely
denervated (Wright and Son, 2007; Wright et al., 2007,
2014). Whole-mounted diaphragms were imaged on a
FluoView FV1000 confocal microscope (Olympus; RRID:
SCR_014215). We conducted NMJ analysis on ipsilateral
hemidiaphragm as our previous work indicated no denervation or sprouting in the contralateral hemidiaphragm
after cervical SCI (Nicaise et al., 2012).
Glial scar quantification
Here, 30-m sagittal tissue sections of cervical spinal
cord were immunostained with anti-GFAP antibody (as
described above). The rostral-to-caudal width of the
GFAP⫹ scar was measured on a Zeiss Axio M2 Imager
using MetaMorph software at five equidistant locations
starting at the dorsal end of the hemisection and going
to the ventral end of the injury to account for changes in
scar size through the dorsal-ventral extent of the tissue.
At each location, scar width measurements were calculated starting at the edge of the lesion (i.e., the
location where the GFAP⫹ scar meets the GFAP– lesion site) and extending through the dense, continuous
band of interdigitated astrocytes with highly-upregulated levels of GFAP expression. These glial scar
measurements were collected on both rostral and caudal sides of the lesion. All 10 measurements per single
section (5 on each side of the lesion) were then averaged, and each animal had 10 tissue sections analyzed
to calculate a single mean value for glial scar width per
animal (n ⫽ 3 animals per group).
Lesion quantification
Here, 30-m sagittal tissue sections of cervical spinal
cord were stained with cresyl violet (as described above).
September/October 2019, 6(5) ENEURO.0096-19.2019
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The lesion was measured on a Zeiss Axio M2 Imager
using MetaMorph software at five equidistant locations
starting at the dorsal end of the hemisection and going to
the ventral end of the injury to account for changes in
lesion size through the tissue (Urban et al., 2018). All
five measurements per section were averaged, and each
animal had 12 sections of tissue analyzed to determine a
value for lesion size per animal (n ⫽ 3 animals per
group).
Experimental design and statistical analysis
In the Results section, we provide details of exact ns,
group means, SEM, statistical tests used, and the results
of all statistical analyses (including exact p values, t values, and F values) for each experiment and for all statistical comparisons. Statistical significance was assessed
by ANOVA and multiple comparisons post hoc test; t test
was used for analysis involving only two groups. GraphPad Prism 6 (GraphPad Software Inc.; RRID: SCR_002798)
was used to calculate all analyses, and p ⬍ 0.05 was
considered significant. We replicated this study in two
completely separate experiments conducted approximately nine months apart. Importantly, we observed the
same outcome with both the functional EMG experiments and the analysis of rVRG axon regeneration in
the two studies, demonstrating reproducibility of the
robust effects of PAP4 administration after cervical
SCI.
We authenticated relevant experimental regents to ensure that they performed similarly across experiments and
to validate the resulting data. We generated the AAV2mCherry vector in-house. Whenever we used a new batch
of the vector, we verified that the virus performed equivalently from batch-to-batch by confirming in every animal
that the vector transduced cells of the rVRG, transduced
predominantly NeuN-positive neurons and induced expression of the mCherry tracer in the soma and axonal
projections of these cells. If viral delivery was unsuccessful because of mis-targeting of the intra-medullary injection or because lack of mCherry expression, we would not
use this animal for analysis of the rVRG axonal growth
response. We histologically verified lesion completeness
of the C2 hemisection in all animals. If a rat showed an
incomplete lesion, the animal would be completely excluded from the study for all analyses. Whenever a new
batch of peptide was used (i.e., in the two replication
experiments), we validated that systemic administration
of PAP4 was able to increase levels of pS6K70 in the
soma of rVRG neurons using immunostaining of brainstem sections. For Alexa-conjugated ␣-bungarotoxin and
for all antibodies used in the immunohistochemistry studies, we always verified (when receiving a new batch from
the manufacturer) that labeling in the spinal cord, brainstem and/or diaphragm muscle coincided with the established expression pattern of the protein. We have
provided RRID numbers for all relevant reagents (i.e.,
antibodies and computer programs) throughout Materials
and Methods.
eNeuro.org
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Results
C2 hemisection disrupted rVRG-PhMN-diaphragm
circuitry
Under intact physiologic conditions, inspiratory signals
originating from the rVRG are mono-synaptically relayed
to PhMNs of the C3–C5 spinal cord that directly innervate
the ipsilateral hemidiaphragm (Fig. 1A; Dobbins and Feldman, 1994). There is also some bulbospinal input to
PhMNs from the contralateral rVRG. After C2 hemisection, rVRG fibers are axotomized, resulting in hemidiaphragm paralysis (Urban et al., 2018). To test the effect of
PTEN inhibition on rVRG axon regeneration, we subjected
adult female Sprague Dawley rats to C2 hemisection SCI
(Alilain et al., 2011), followed by 2⫻ daily subcutaneous
injections of PAP4 or DMSO-only control starting 3 d after
injury and continuing for 21 d (Fig. 1D). At two weeks after
injury, we performed intra-medullary injection of an AAV2mCherry vector to anterogradely-label rVRG axons (Urban
et al., 2018). In separate cohorts, we transduced neurons
of either the ipsilateral rVRG to assess regeneration of
damaged axons (Fig. 1B) or the contralateral rVRG to test
for sprouting of spared fibers within the PhMN pool ipsilateral to the lesion (Fig. 1C). Four days before killing, we
performed CMAP recordings from both the ipsilateral and
contralateral hemidiaphragm to examine functional innervation of the muscle by PhMNs (Lepore et al., 2008,
2010). We also performed intrapleural injection of the
retrograde tracer, cholera toxin subunit B, at this same
time point to selectively label PhMN soma within the
cervical spinal cord (Li et al., 2014, 2015a). At eight weeks
following SCI, we conducted EMG recordings from anesthetized rats under normal eupnic breathing conditions to
assay functional diaphragm activation and rhythmic bulbospinal drive to the PhMNs (Nicaise et al., 2012, 2013). A
subset of PAP4-treated and DMSO-treated animals underwent a re-lesion at eight weeks after injury to determine whether axon regeneration through the injury site
was causally responsible for functional diaphragm recovery; in this experiment, EMG recordings were performed
on the same animal at eight weeks after injury both before
and after the re-lesion procedure. All animals were killed
at eight weeks after SCI.
Increased mTOR signaling in rVRG neurons
We first verified complete hemisection in all animals by
performing cresyl violet staining on both sagittal and
transverse sections of injured spinal cord. We found complete medial-to-lateral (Fig. 2A) and dorsal-to-ventral (Fig.
2B) ablation of the hemicord, indicating complete disruption of descending rVRG axons within the ipsilateral spinal
cord. We found no difference in the average width of the
lesion site as determined by the distance from the rostral
to the caudal lesion borders between the DMSO controls
and the PAP4 group (DMSO: 521 ⫾ 51.9 m, n ⫽ 4;
PAP4: 466 ⫾ 30.1 m, n ⫽ 4; p ⫽ 0.39, t test; Fig. 2C).
We next evaluated the efficiency of transduction of
rVRG neurons using the AAV2-mCherry tracer. Transverse tissue sections of the brainstem revealed robust
expression of mCherry within the rVRG (Fig. 2D), with viral
transduction restricted to cells displaying a neuronal morSeptember/October 2019, 6(5) ENEURO.0096-19.2019
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phology (Fig. 2E,F). Using this same AAV2-mCherry vector, we previously showed that ⬃95% of transduced cells
within the rVRG are NeuN-expressing neurons (Urban
et al., 2018).
We next tested the effect of PAP4 on the mTOR signaling axis. mTOR pathway stimulation results in downstream phosphorylation and activation of S6 kinase (S6K;
Kanno et al., 2012). We previously showed that pS6K
levels in ipsilateral rVRG neurons are significantly decreased
following C2 hemisection compared to laminectomy-only
(Urban et al., 2018). We first determined pS6K expression
within mCherry-labeled neurons of the rVRG by immunostaining mCherry⫹ brainstem sections with NeuN and
pS6K (Fig. 2G–J). We found that pS6K immunostaining
co-labeled with NeuN-positive rVRG neurons that also
were transduced by the AAV2-mCherry vector. We quantified pS6K fluorescence intensity per mCherry⫹ rVRG
neuron specifically and found a significant increase in
pS6K levels in the PAP4 group (Fig. 2K) compared to
DMSO control (Fig. 2L) at eight weeks after injury [DMSO:
104 ⫾ 2 (a.u.), n ⫽ 129 rVRG neurons; PAP4: 132 ⫾ 4 a.u.,
n ⫽ 118; p ⬍ 0.0001; t test; Fig. 2M), indicating that
systemic PAP4 delivery was effective in activating the
mTOR pathway in rVRG neurons. These data likely underestimate the effect given that we stopped PAP4 delivery
at three weeks after injury, while we quantified pS6K
levels at eight weeks after hemisection. While we observed increased pS6K levels in rVRG neurons with PAP4,
we have not shown that this effect of PAP4 is directly on
rVRG neurons, particularly considering the long duration
between the end of peptide treatment and the time of
analysis.
Glial scar formation was not affected by PAP4
The glial scar plays a critical role after SCI in both
limiting secondary damage (Faulkner et al., 2004) and
inhibiting axon growth (Silver et al., 2015). As glial scar
formation after a severe insult such as hemisection SCI
involves significant cell proliferation (Faulkner et al., 2004)
and because PTEN plays a central role in the control of
cell division, we assessed whether systemic PAP4 treatment influenced scar formation or lesion size, effects that
could indirectly influence the rVRG axon growth response.
To evaluate astrocyte scar formation, we immunostained
sagittal spinal cord sections with the astrocyte marker
GFAP. On both rostral and caudal sides of the lesion, we
quantified the rostral-to-caudal width of the GFAPpositive scar at five equidistant locations (five locations on
both sides) along the dorsal-ventral expanse of the injury.
Compared to DMSO-only control (Fig. 2N), PAP4 (Fig. 2O)
did not alter the width of the astroglial scar (DMSO: 217 ⫾
28.9 m, n ⫽ 3; PAP4: 183 ⫾ 34.1 m, n ⫽ 3; p ⫽ 0.49;
t test; Fig. 2P). These data are suggestive of a lack of
PAP4 effects on scar formation; nevertheless, additional
experiments are necessary to more conclusively rule out
the possibility that PAP4 impacted the glial scar response.
Diaphragm function was significantly restored by
PAP4
To test for diaphragmatic functional recovery, we performed EMG recordings in anesthetized living animals
eNeuro.org
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Figure 2. Increased mTOR signaling in rVRG neurons. At eight weeks after hemisection, cresyl violet staining of both transverse (A)
and sagittal (B) sections shows complete dorsal-ventral and medial-lateral ablation of the spinal cord. No difference was observed
between DMSO and PAP4 groups in rostral-to-caudal lesion size (C); scale bars: 1 mm (A), 1 mm (B). Fluorescent microscopy of
coronal brainstem sections shows AAV2-mCherry injections into the rVRG (D); higher magnification images reveal robust expression
of mCherry and neuronal morphology of transduced cells in rVRG (E, F); scale bars: 1 mm (D), 500 m (E), and 100 m (F). mCherry⫹
coronal brainstem sections immunostained with NeuN and pS6K show co-localization of pS6K in NeuN⫹ neurons within the rVRG
(G–J); scale bar: 100 m. At eight weeks after injury, immunofluorescence imaging shows that PAP4-treated animals had significantly
higher levels of pS6K in ipsilateral rVRG neurons compared to DMSO-treated controls (K, L); scale bar: 100 m; total fluorescence
per mCherry⫹ cell was averaged for each animal and the mean of each group is represented in M. Immunofluorescence imaging
revealed no change in GFAP⫹ glial scar size at eight weeks after hemisection between DMSO (N) and PAP4 (O) groups; scale bar:
September/October 2019, 6(5) ENEURO.0096-19.2019
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continued
200 m. Yellow dotted lines represent the rostral and caudal borders of the glial scar at the lesion site. Quantification of glial scar width
shown in P; n ⫽ 10 sagittal sections per animal and n ⫽ 3 animals per group for quantification. ⴱp ⬍ 0.05.

from three different subregions of the diaphragm: dorsal,
medial, and ventral (Fig. 3D). We and others have previously shown that the ventral subregion is primarily innervated by PhMNs located at C3, the medial subregion is
controlled by C4 PhMNs, and the dorsal subregion is
innervated by PhMNs residing at C5 (Laskowski and
Sanes, 1987; Li et al., 2014). Compared to DMSO-only
control (Fig. 3B,B’), PAP4 promoted significant functional
recovery (Fig. 3C,C’) at all three subregions of the ipsilateral hemidiaphragm (Fig. 3E). In the dorsal (intact: 5.9 ⫾
0.4 mV/s, n ⫽ 9; DMSO: 0.2 ⫾ 0.14 mV/s, n ⫽ 8; PAP4:
3.7 ⫾ 0.8 mV/s, n ⫽ 9) and medial (intact: 6.4 ⫾ 0.4 mV/s,
n ⫽ 9; DMSO: 0.6 ⫾ 0.2 mV/s, n ⫽ 8; PAP4: 3.7 ⫾ 0.8
mV/s, n ⫽ 9) subregions, PAP4-induced recovery was
partial as the EMG amplitudes were less than uninjured
laminectomy-only rats (dorsal: F(2,23) ⫽ 27.15; Tukey’s

post hoc test; intact vs DMSO: p ⫽ 0.0002; intact vs
PAP4: p ⫽ 0.2; DMSO vs PAP4: p ⫽ 0.03; medial: F(2,23) ⫽
24.5; Tukey’s post hoc test medial: intact vs DMSO: p ⬍
0.001; intact vs PAP4: p ⫽ 0.10; DMSO vs PAP4: p ⫽
0.06; ANOVA; Fig. 3A,A’,E), while PAP4 promoted complete recovery back to uninjured control levels in the
ventral subregion (ventral: intact: 7.1 ⫾ 0.9 mV/s, n ⫽ 9;
DMSO: 1.6 ⫾ 0.2 mV/s, n ⫽ 8; PAP4: 6.8 ⫾ 0.8 mV/s, n ⫽
8; F(2,22) ⫽ 20.9; Tukey’s post hoc test; intact vs DMSO: p
⬍ 0.0001; intact vs PAP4: p ⫽ 0.97; DMSO vs PAP4: p ⬍
0.0001; ANOVA; Fig. 3E). Additionally, PAP4 had no effect
on EMG burst frequency (DMSO: 40 ⫾ 2.6 bursts/min, n
⫽ 4; PAP4: 39 ⫾ 5.5 bursts/min, n ⫽ 4; p ⫽ 0.90, t test;
Fig. 3F), while EMG duty cycle was significantly increased
with treatment (DMSO: 0.14 ⫾ 0.01, n ⫽ 4; PAP4: 0.23 ⫾
0.01, n ⫽ 4; p ⫽ 0.004, t test; Fig. 3G) in the ventral

Figure 3. Diaphragm function was significantly restored by PAP4 following C2 hemisection. At eight weeks after injury, EMG
recordings were assessed from uninjured, DMSO-treated hemisection, and PAP4-treated hemisection groups. EMG amplitudes were
recorded at three subregions of the hemidiaphragm: dorsal, medial, and ventral regions (D). Both DMSO-treated and PAP4-treated
groups were compared to intact (laminectomy-only) animals. Representative EMG traces from the ventral region of the diaphragm
show that compared to laminectomy-only animals (A, A’), DMSO-treated rats (B, B’) had a significant decrease in inspiratory EMG
burst amplitude at eight weeks after injury. Animals treated with PAP4 (C, C’) showed significant recovery of EMG amplitude following
injury. Quantification of EMG recordings at the three hemidiaphragm regions (E). Ventral subregion EMG burst frequency was
unaffected by PAP4 treatment (F). EMG duty cycle was increased by PAP4 (G). ⴱp ⬍ 0.05. ⴱⴱp ⬍ 0.01. ⴱⴱⴱp ⬍ 0.001. ns, not
significant p ⱖ 0.05.
September/October 2019, 6(5) ENEURO.0096-19.2019
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Figure 4. Functional and morphologic innervation of the diaphragm was unaffected by PAP4. CMAP recordings obtained from the
ipsilateral hemidiaphragm show no differences in amplitude among laminectomy-only (A), DMSO (B), and PAP4 (C) groups. Similarly,
no differences were noted in CMAP amplitudes obtained in the contralateral hemidiaphragm among laminectomy-only (A’), DMSO
(B’), and PAP4 (C’) groups. Quantification of CMAP amplitudes showed no differences among groups or between ipsilateral and
contralateral hemidiaphragm (D). Representative confocal z-stack image showing labeling of the diaphragm NMJ for the pan-axonal
marker SMI-312 (green; F, H), the synaptic vesicle marker SV2 (green; F, H), and the marker of postsynaptic nicotinic acetylcholine
receptors ␣-bungarotoxin (red; G, H). Nearly all NMJs in the ipsilateral hemidiaphragm remained fully innervated at eight weeks after
hemisection; scale bar 50 m. Quantification of the dorsal, medial, and ventral portions of the hemidiaphragm showed no differences
in the percentage of fully-innervated, partially-denervated, or completely-denervated NMJs between the DMSO and PAP4 groups (E);
n ⫽ 3 and n ⫽ 4 rats for DMSO and PAP4, respectively; 16 tissue sections per animal analyzed.

subregion. These findings demonstrate that systemic delivery of PAP4 (starting with a delay of 3 d after injury)
promoted significant recovery of diaphragmatic respiratory function after cervical SCI.
Functional and morphologic innervation of the
diaphragm was unaffected by PAP4
To evaluate functional innervation of the hemidiaphragm, we performed nerve conduction studies in which
we supra-maximally stimulated the phrenic nerve with a
September/October 2019, 6(5) ENEURO.0096-19.2019

transcutaneous needle electrode and recorded the CMAP
response across the entire ipsilateral hemidiaphragm with
a surface electrode. Representative CMAP traces show
no differences in CMAP amplitude among uninjured control (ipsilateral: 7.1 ⫾ 0.3 mV; contralateral: 6.9 ⫾ 0.2 mV;
Fig. 4A,A’), DMSO-only hemisection (ipsilateral: 6.7 ⫾ 0.5
mV; contralateral: 7.0 ⫾ 0.3 mV; Fig. 4B,B’), and PAP4treated hemisection (ipsilateral: 7.8 ⫾ 0.3 mV; contralateral: 7.7 ⫾ 0.5 mV; Fig. 4C,C’) rats in the ipsilateral
hemidiaphragm (F(2,30) ⫽ 0.35; Tukey’s post hoc test;
eNeuro.org
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intact vs DMSO: p ⫽ 0.95; intact vs PAP4: p ⫽ 0.75;
DMSO vs PAP4: p ⫽ 0.25; ANOVA; n ⫽ 6 rats per group;
Fig. 4D). In addition, we found no differences in CMAP
amplitudes obtained from hemidiaphragm ipsilateral and
contralateral to the injury site in all groups (F(1,30) ⫽ 0.01;
Tukey’s post hoc test; intact: p ⫽ 0.99; DMSO: p ⫽ 0.97;
PAP4: p ⬎ 0.99; ANOVA; n ⫽ 6 rats per group; Fig. 4A–D).
To quantify morphologic innervation, we performed immunolabeling of whole-mount hemidiaphragm muscle.
We used SMI-312/neurofilament and synaptic vesicle
protein 2 (SV2) antibodies to label phrenic motor axons all
the way to their presynaptic terminals (Fig. 4F,H), and we
labeled postsynaptic nicotinic acetylcholine receptors in
the muscle with Alexa-conjugated ␣-bungarotoxin (Fig.
4G,H; Wright and Son, 2007; Wright et al., 2007, 2014).
Confocal acquisition of z-stack projections revealed intact
innervation of nearly all NMJs in both the DMSO-only
(ventral: intact ⫽ 85.1 ⫾ 8.3%; partial denervation ⫽ 4.8 ⫾
4.8%; complete denervation ⫽ 10.1 ⫾ 5.1%; medial intact
⫽ 81.9 ⫾ 9.1%; partial denervation ⫽ 7.2 ⫾ 4.9%, complete denervation ⫽ 10.8 ⫾ 5.8%; dorsal: intact ⫽ 98.4 ⫾
1.5%; partial denervation ⫽ 0.76 ⫾ 0.76%, complete
denervation ⫽ 0.7 ⫾ 0.8%; n ⫽ 3 rats per group for all
analyses) and PAP4 (ventral: intact ⫽ 96.2 ⫾ 1.9, partial
denervation ⫽ 3.8 ⫾ 1.9; complete denervation ⫽ 0.0 ⫾
0.0; medial: intact ⫽ 88.6 ⫾ 1.1%; partial denervation ⫽
8.0 ⫾ 0.7%; complete denervation ⫽ 3.4 ⫾ 0.4%; dorsal:
intact ⫽ 94.6 ⫾ 3.2%; partial denervation ⫽ 1.9 ⫾ 1.9%;
complete denervation ⫽ 3.5 ⫾ 2.2%; n ⫽ 3– 4 rats per
group for all analyses) groups (Fig. 4H); 90 –100% of all
NMJs were fully-innervated in all animals. Following quantitative analysis, we found no differences between DMSOonly and PAP4 in the percentage of NMJs in each
subregion of ipsilateral hemidiaphragm that were intact
(F(2,14) ⫽ 1.25; Tukey’s post hoc test; dorsal: p ⫽ 0.97;
medial: p ⫽ 0.78; ventral subregion: p ⫽ 0.34; ANOVA),
partially-denervated (F(2,14) ⫽ 0.08; Tukey’s post hoc test;
dorsal: p ⬎ 0.99; medial: p ⬎ 0.99; ventral subregion: p ⬎
0.99; ANOVA) or completely-denervated (F(2,14) ⫽ 2.52;
Tukey’s post hoc test; dorsal: p ⫽ 0.99; medial: p ⫽ 0.69;
ventral subregion: p ⫽ 0.44; ANOVA; Fig. 4E).
Collectively, these data demonstrate that C2 hemisection resulted in no functional or morphologic denervation
of the diaphragm by PhMNs and that PAP4 had no effect
on diaphragm innervation compared to DMSO control.
PAP4 promoted rVRG axon regeneration through the
lesion and into caudal spinal cord
To determine effects of PAP4 on the growth response
of damaged rVRG axons, we injected AAV2-mCherry into
rVRG ipsilateral to hemisection. Specific locations of
where images were obtained are diagramed in Figure 5A.
Treatment with DMSO-only resulted in no regeneration at
all into the lesion site (Fig. 5E,G) or through the lesion
back into intact caudal spinal cord (Fig. 5G,I), coinciding
with our previous work showing that injured rVRG axons
do not regenerate following SCI (Urban et al., 2018). On
the contrary, PAP4 induced robust long-distance regeneration of ipsilateral rVRG axons into the lesion (Fig. 5F,H),
through the caudal lesion-intact interface (Fig. 5J) and
September/October 2019, 6(5) ENEURO.0096-19.2019
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back to the PhMNs (Fig. 5K,L). In sagittal sections, we
quantified the total number of mCherry-labeled rVRG fibers in individual 100m-wide bins starting at the rostral
end of the lesion and proceeding in both rostral and
caudal directions (Fig. 5B; Urban et al., 2018). Quantification of this regeneration shows that mCherry-labeled
rVRG axons regenerated along the cervical spinal cord up
to at least 4.5 mm from the distal lesion-intact interface
(i.e., regeneration to the caudal portion of the PhMN pool),
although we observed the greatest degree of regeneration
closer to the injury at C3 (F(1,5) ⫽ 38.5 Tukey’s post hoc
test; ANOVA; n ⫽ 3 and n ⫽ 4 rats for DMSO and PAP4,
respectively; 16 tissue sections per animal analyzed). We
found no differences between the DMSO and PAP4
groups in number of mCherry-labeled axons at any distance ⱖ500 m rostral to the lesion, suggesting equivalent rVRG neuron labeling with our AAV2-mCherry
injections in the two groups.
Regenerating rVRG axons formed putative synaptic
connections with PhMNs
We next evaluated whether the regenerating rVRG axons made putative synaptic connections with denervated
PhMNs ipsilateral to the injury. We performed triplelabeling with the excitatory presynaptic marker VGLUT2,
DsRed (to enhance the mCherry signal) and CTB. We
assessed the number of putative synaptic connections
specifically between mCherry-positive rVRG fibers and
CTB-labeled PhMN cell bodies at level C3 using confocal
acquisition of z-stacks and quantification of rVRG axonPhMN contacts using single-Z section analysis to establish direct apposition of presynaptic VGLUT2⫹/mCherry⫹
axon terminals and postsynaptic CTB⫹ PhMNs (Urban
et al., 2018). Compared to DMSO-only that showed no
putative rVRG-PhMN synaptic connection at all (0.0 ⫾ 0.0
connections per CTB⫹ PhMN; images not shown), PAP4treated animals showed significant synaptic reinnervation
of PhMNs located ipsilateral/caudal to the lesion by regenerating rVRG axons (1.9 ⫾ 0.6 connections per CTB⫹
PhMN; Fig. 5K–N,O–R); this quantification likely significantly underestimates the degree of synaptic connections
given that CTB only marks the cell body and proximal
dendrites of PhMNs and not the more distal dendritic
processes. These findings demonstrate that, not only did
injured rVRG axons undergo long-distance regeneration
across the cervical SCI site, they importantly partially
reconnected the original circuit by forming synaptic contacts with their PhMN targets.
Sprouting of contralateral rVRG fibers
We also explored modes of anatomic plasticity that
could potentially underlie functional recovery besides regeneration of injured ipsilateral rVRG axons (Goshgarian
et al., 1991; Boulenguez et al., 2007). Most human SCI
cases are anatomically-incomplete (Ahuja et al., 2017),
providing a substrate of spared axons that can sprout to
form novel connections for reinnervating neuronal populations distal to a spinal cord lesion. In a separate cohort
of animals, we labeled axons spared by the injury originating in the contralateral rVRG with AAV2-mCherry. In
the ipsilateral ventral horn at locations caudal to the leeNeuro.org
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Figure 5. Ipsilateral rVRG axons regenerated through the lesion and formed putative synaptic connections with PhMNs. At eight
weeks after injury, sagittal sections of the cervical spinal cord were examined for growth of mCherry-labeled axons originating in the
ipsilateral rVRG at multiple locations relative to the lesion (A). Dotted boxes denote locations of images in subsequent panels, red lines
represent rVRG axons, and green triangles represent PhMNs. Representative images of the lesion site reveal mCherry-labeled rVRG
fibers were able to regenerate into and through the lesion and then back into the intact caudal spinal cord in PAP4-treated rats (D,
F, H, J), but not the DMSO-only controls (C, E, G, I); scale bars: 100 m (C, D), 40 m (E–J). Quantification of mCherry-labeled rVRG
axon growth in 100 m rostral-to-caudal bins using the rostral end of the lesion as the starting point (B). Confocal imaging show that
regenerating mCherry⫹ rVRG axons (L, N, P, R; arrowheads in L) formed putative VGLUT2⫹ excitatory synaptic connections (M, N,
Q, R) with CTB⫹ PhMNs retrogradely-labeled from the ipsilateral hemidiaphragm (K, N, O, R); scale bars: 50 m (K–N), 30 m (O–R).
Orthogonal projection shows mCherry⫹/VGLUT2⫹ excitatory rVRG axon terminals located directly presynaptic to the soma of CTB⫹
PhMNs in the C3 spinal cord (R; arrowheads in O–R). Dotted box in panel N denotes location of panels O–R. No mCherry-labeled
rVRG fibers were found at all in the ipsilateral PhMN pool of DMSO-treated controls (data not shown). ⴱp ⬍ 0.05.

sion, we assessed the total number of mCherry-labeled
axon profiles within the CTB-labeled PhMN pool at 3
regions that correspond to C3 (1.5 mm from the caudal
end of the lesion), C4 (3.0 mm), and C5 (4.5 mm) levels.
Even in intact conditions and following C2 hemisection
alone (i.e., no treatment), we found contralateral-originating rVRG axonal input to the PhMNs (data not
shown), although levels were lower than input coming
from the ipsilateral rVRG. We found no significant differences in total number of mCherry-labeled rVRG axon
September/October 2019, 6(5) ENEURO.0096-19.2019

profiles between DMSO-only (C3: 7.7 ⫾ 1.0 axon profiles;
C4: 5.1 ⫾ 1.4; C5: 8.4 ⫾ 1.5; Fig. 6B,C) and PAP4 (C3: 6.2
⫾ 0.7 axon profiles; C4: 6.9 ⫾ 1.0; C5: 7.2 ⫾ 1.1; Fig.
6A,C) at any of these three distances (F(1,18) ⫽ 0.33;
Tukey’s post hoc test; C3: p ⫽ 0.06; C4: p ⫽ 0.08; C5: p
⫽ 0.27; t test; n ⫽ 4 rats per group; 12 tissue sections
analyzed per animal; Fig. 6C), suggesting that increased
drive from spared contralateral rVRG to ipsilateral PhMNs
was likely not responsible for recovery. PAP4 treatment
increased the number of mCherry-labeled axons originateNeuro.org
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Figure 6. Sprouting of spared fibers originating in the contralateral rVRG. At eight weeks after injury, sagittal sections of the cervical
spinal cord were examined for growth of mCherry-labeled axons originating in the contralateral rVRG at level C3, C4, and C5 (A).
Representative images show no difference between DMSO control (A) and PAP4 (B) in the density of mCherry-labeled rVRG fibers
in the C3 ventral horn ipsilateral to the lesion; yellow arrowheads in A, B denote mCherry⫹ rVRG axons; scale bar: 100 m.
Quantification of the number of contralateral-originating rVRG fibers per area present within the ipsilateral ventral horn at levels
C3–C5 (C). Distances from the lesion correspond to spinal cord levels: ⫹1.5 mm to C3 (A, B), ⫹3.0 mm to C4, ⫹4.5 mm to C5;
n ⫽ 4 rats per group; n ⫽ 12 tissue sections analyzed per animal. PAP4 treatment increased the number of mCherry-labeled
axons originating in the contralateral rVRG within the contralateral C3 ventral horn (D); n ⫽ 3 rats per group; nine tissue sections
analyzed per animal. ⴱp ⬍ 0.05.

ing in the contralateral rVRG within the contralateral C3
ventral horn (DMSO: 32.8 ⫾ 2.1 axon profiles; PAP4: 50.2
⫾ 2.0 axon profiles; n ⫽ 9; p ⬍ 0.0001, t test; Fig. 6D),
demonstrating that, while PAP4 did not have effects on
these axons within the ipsilateral PhMN pool, systemic
delivery of a PTEN inhibitor can stimulate plasticity of
spared bulbospinal axon populations in the spinal cord.
PAP4 promoted 5-HT axon growth and synaptic
innervation of PhMNs caudal to the lesion
Descending serotonergic input plays an important role
in regulating the excitability of spinal cord motor neurons,
in particular their response to glutamatergic signaling
(Perrier et al., 2013). In the context of diaphragm function,
PAP4 may be able to strengthen rhythmic excitatory input
to PhMNs from spared and/or regrowing rVRG axons by
increasing serotonergic innervation of PhMNs via 5-HT
fiber sprouting (Mitchell et al., 1992; Zhou et al., 2001;
Mantilla et al., 2012). To address this possibility, we quantified 5-HT immunostaining in the C3–C5 ventral horn
ipsilateral to the C2 hemisection (Ghosh et al., 2018).
Compared to DMSO-only (Fig. 7A–C), we found that
PAP4 (Fig. 7D–F) enhanced the density of serotonergic
axons directly surrounding CTB-labeled PhMNs at levels
C3–C5. We conducted this analysis of 5-HT fiber growth
within the CTB-labeled PhMN pool by performing quantification of (1) numbers of 5-HT⫹ axon profiles, (2) length
of these 5-HT⫹ axon profiles, and (3) integrated intensity
of 5-HT immunostaining (Ghosh et al., 2018). Compared
to DMSO-only, PAP4 treatment increased the number of
September/October 2019, 6(5) ENEURO.0096-19.2019

5-HT⫹ axonal profiles (DMSO: 37.0 ⫾ 10.0 axon profiles;
PAP4: 155.0 ⫾ 24.9 profiles, t test, p ⬍ 0.001; Fig. 7G)
and total 5-HT⫹ axonal length (DMSO: 78.9 ⫾ 17.7 m;
PAP4: 347.5 ⫾ 54.5 m, t test, p ⬍ 0.001; Fig. 7H). In
addition, PAP4 increased integrated intensity of 5-HT
immunostaining compared to DMSO-only (DMSO: 2.8 ⫾
0.7 a.u.; PAP4: 10.6 ⫾ 0.98 a.u; t test, t test; p ⬍ 0.001;
Fig. 7I). PAP4 treatment also stimulated serotonergic
axon sprouting in the contralateral PhMN pool, demonstrating that effects of PAP4 on 5-HT axon plasticity were
not restricted to only the side of injury (DMSO: 148.0 ⫾
21.1 profiles; PAP4: 540.7 ⫾ 64.7 profiles; n ⫽ 3; p ⫽
0.005, t test; Fig. 7J).
Lastly, we conducted quantitative analysis of synaptic
input to ipsilateral PhMNs by serotonergic axons using
multi-labeling immunohistochemistry for 5-HT⫹ axons,
CTB⫹ postsynaptic PhMNs and the presynaptic marker
synaptophysin. We assessed the number of putative synaptic connections between 5-HT fibers and CTB-labeled
PhMNs at levels C3–C5 using confocal acquisition of
z-stacks and quantification of 5-HT axon-PhMN contacts
using single-Z section analysis to establish direct apposition of presynaptic 5-HT⫹/synaptophysin⫹ axon terminals and postsynaptic CTB⫹ PhMNs (Ghosh et al., 2018;
Fig. 7K–O). Compared to DMSO-only (C3: 2.1 ⫾ 0.2, C4:
1.7 ⫾ 0.2, C5: 1.6 ⫾ 0.3 contacts per PhMN soma), PAP4
animals (C3: 3.5 ⫾ 0.3, C4: 3.2 ⫾ 0.7, C5: 3.5 ⫾ 0.2
contacts per PhMN cell body) showed significantly more
putative synaptic contacts between 5-HT axons and
PhMNs (C3: p ⫽ 0.056, C4: p ⫽ 0.045, C5: p ⫽ 0.013;
eNeuro.org
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Figure 7. PAP4 promoted 5-HT axon growth and synaptic innervation of PhMNs caudal to the lesion. Compared to DMSO-only (A–C),
PAP4 (D–F) enhanced the density of serotonergic axons directly surrounding CTB-labeled PhMNs at levels C3–C5; scale bar: 100 m.
Quantification demonstrates that PAP4 treatment increased the number of 5-HT⫹ axonal profiles (G), total length of 5-HT⫹ axonal
profiles (H), and the integrated intensity of 5-HT immunostaining (I) compared to DMSO. PAP4 also increased the number of 5-HT⫹
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continued
axon profiles surrounding CTB-labeled PhMNs in the contralateral spinal cord (J). We also assessed the number of putative
synaptophysin⫹ (L) synaptic connections between 5-HT axons (M) and CTB-labeled PhMNs (K) at levels C3–C5 using single-Z
section analysis to establish direct apposition of presynaptic 5-HT⫹/synaptophysin⫹ axon terminals and postsynaptic CTB⫹ PhMNs
(N). Compared to DMSO-only, PAP4 animals significantly increased the number of putative synaptic contacts between 5-HT axons
and CTB-labeled PhMNs in the C3–C5 spinal cord ipsilateral to the hemisection (O). ⴱp ⬍ 0.05.

unpaired t test; n ⫽ 3 rats per group for all analyses; Fig.
7N).
Effects of re-lesion on PAP4-induced restoration of
diaphragm function
Given the robust degree of rVRG axon regeneration and
rVRG-PhMN synaptic reconnectivity we observed following PAP4 administration, we sought to determine whether
regeneration was causally responsible for the resulting
recovery of diaphragm function. Again at eight weeks

after injury, we conducted EMG recordings both before
(dorsal: DMSO: 0.3 ⫾ 0.3 mV/s, n ⫽ 3; PAP4: 4.0 ⫾ 1.0,
n ⫽ 4; medial: DMSO: 1.2 ⫾ 0.2, n ⫽ 3; PAP4: 3.5 ⫾ 0.5,
n ⫽ 4; ventral: DMSO: 1.6 ⫾ 0.1, n ⫽ 3; PAP4: 6.1 ⫾ 0.9,
n ⫽ 3) and after (dorsal: DMSO: 0.1 ⫾ 0.1 mV/s, n ⫽ 3;
PAP4: 1.3 ⫾ 0.5, n ⫽ 4; medial: DMSO: 0.6 ⫾ 0.2, n ⫽ 3;
PAP4: 1.8 ⫾ 0.2, n ⫽ 4; ventral: DMSO: 1.2 ⫾ 0.4, n ⫽ 3;
PAP4: 2.6 ⫾ 0.4, n ⫽ 3) a surgical re-lesion through the
center of the injury site in a subset of animals (Fig. 8A–D).
Re-lesion had no effect on the small degree of recovery

Figure 8. Effects of re-lesion on PAP4-induced restoration of diaphragm function. At eight weeks after hemisection, we performed
a re-lesion through the C2 injury site of both DMSO-only and PAP4 groups. Representative traces of EMG recordings from the ventral
hemidiaphragm show no change in EMG amplitude recordings between DMSO pre-re-lesion and DMSO post-re-lesion groups (A, B).
There was a significant loss of inspiratory burst amplitude following the re-lesion (D) in the PAP-treated group compared to the
recordings immediately before re-lesion in the same animal (C). Quantification of inspiratory EMG bursts in the dorsal, medial and
ventral subregions of the ipsilateral hemidiaphragm before and after re-lesion (E). ⴱp ⬍ 0.05. ⴱⴱp ⬍ 0.01. ⴱⴱⴱp ⬍ 0.001. ns, not
significant p ⱖ 0.05.
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observed with DMSO (F(1,12) ⫽ 4.40; Tukey’s post hoc
test; dorsal: p ⬎ 0.99; medial: p ⬎ 0.99; ventral: p ⬎ 0.99;
ANOVA; Fig. 8A,B,E); this modest functional improvement
is normally observed after C2 hemisection and is likely
driven by spared contralateral rVRG input that is present
even in intact conditions (Goshgarian et al., 1991; Boulenguez et al., 2007). On the contrary, PAP4-stimulated
recovery was lost with re-lesion at all three subregions of
the ipsilateral hemidiaphragm (Fig. 8C,D,E). Representative traces from the ventral hemidiaphragm following
PAP4 administration show inspiratory bursts in the same
animal both immediately before and after re-lesion (Fig.
8A–D). EMG burst amplitudes after re-lesion of PAP4 rats
were significantly reduced compared to the same PAP4treated animals before re-lesion (F(1,16) ⫽ 24.54; Tukey’s
post hoc test; dorsal: p ⫽ 0.02; medial: p ⫽ 0.41; ventral:
p ⫽ 0.006; ANOVA) and were not significantly different
from C2 hemisection animals treated with DMSO-only
(F(5,28) ⫽ 3.07; Tukey’s post hoc test; dorsal: p ⫽ 0.97;
medial: p ⫽ 0.99; ventral: p ⫽ 0.98; ANOVA). Importantly,
this loss of EMG amplitude in the PAP4 animals was not
due to a spinal shock effect. In a separate study with C2
hemisection rats, we also obtained significant recovery of
ipsilateral hemidiaphragm EMG amplitudes using a different experimental manipulation (i.e., PTP-sigma inhibitory
peptide) that did not promote any axon regeneration
through the lesion. Unlike in the current study with PAP4,
re-lesion of these animals had no effect at all on EMG
recovery in the ipsilateral hemidiaphragm (i.e., the recovery was completely maintained after re-lesion; data not
shown), demonstrating that the re-lesion procedure itself
does not non-specifically compromise EMG amplitude.

Discussion
Promoting the reconstruction of rVRG-PhMN-diaphragm circuitry is a potentially-powerful strategy for addressing respiratory dysfunction after cervical SCI.
Therapies aimed at achieving synaptic reconnection of
rVRG axons with denervated PhMNs after SCI have been
relatively unsuccessful to date. A small number of studies
have begun to show the utility of promoting regrowth of
descending axonal input to the PhMN pool in SCI models
(Charsar et al., 2017). For example, removing the inhibitory glycosaminoglycan side chains from chondroitin sulfate proteoglycans (along with a peripheral nerve graft)
promotes growth of serotonergic axons that regulate
PhMN excitability (Alilain et al., 2011). Our data suggest
this PAP4 approach has profound clinical relevance both
for understanding circuit plasticity and for eventually developing therapies. A number of studies have supported
that PTEN is a major contributor to reduced intrinsic
growth capacity of mature neurons. Although the capacity
for CNS axon regeneration diminishes with age (Geoffroy
et al., 2016), previous work has shown that adult neurons
are able to regenerate through modulation of PTEN activity following injury using selective deletion of PTEN via
several methods, including Cre KO mice (Park et al., 2008;
Sun et al., 2011; Geoffroy et al., 2015), shRNA vectors
(Lewandowski and Steward, 2014) and pharmacological
inhibition (Ohtake et al., 2014). We achieve a significant
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degree of regeneration of injured rVRG axons with systemic delivery of PAP4 alone; rVRG axons regrow through
the C2 hemisection lesion and back toward a large extent
of the denervated PhMN pool (up to two to three segments caudal to injury), although the majority of regenerating rVRG axons only reach the C3 portion. Importantly,
this regeneration is associated with robust recovery of
diaphragm function.
Given that systemic delivery could potentially elicit unwanted side effects, we injected PAP4 for only a restricted
time, yet still achieved significant rVRG axon regeneration. Furthermore, we are following up this work by reducing delivery duration to determine the minimal window
that successfully promotes therapeutic effects. Similarly,
it will be important to determine whether delayed delivery
(including in the setting of chronic injury) can induce rVRG
regeneration and diaphragmatic recovery, particularly as
PTEN inhibition may not be capable of promoting such a
robust axon growth response, for example, after a mature
glial scar has already formed, at longer time points following axonal injury and/or in older animals (Steinmetz
et al., 2005; Ylera et al., 2009; Geoffroy et al., 2016).
The degree of improvement after PAP4 administration
differed across the hemidiaphragm; functional EMG recovery was greatest in the ventral diaphragm subregion,
which receives innervation primarily from the most rostral
PhMNs. Furthermore, regeneration of ipsilateral rVRG axons induced by PAP4 was greatest at C3 (and progressively decreased with caudal distance from the lesion).
This suggests that rVRG regeneration may have played a
particularly important role in recovery for the ventral subregion because of differential rVRG axon plasticity responses across the PhMN pool. It is possible that the
greater levels of rVRG axon regeneration and PhMN reinnervation by these fibers that occurred at the most rostral
PhMN locations (combined with the robust 5-HT sprouting at this rostral location) resulted in the enhanced recovery observed in the ventral subregion, while the
reduced (but still significant) recovery observed at the
medial and dorsal subregions was due to the fact that
only 5-HT axon sprouting occurred at the most caudal
portions of the PhMN pool. It will be important in future
work to perform time-course analysis of rVRG axonal
growth along the cervical spinal cord and to correlate this
process with the timing of EMG recovery in the different
diaphragm subregions; this would be greatly aided by
technologies such as repeated recording from the same
animal using chronically-implanted telemetric electrodes
(Mantilla et al., 2011; Bezdudnaya et al., 2018).
With this work, we sought to determine which modes of
rVRG-PhMN circuit plasticity can drive recovery of respiratory function following cervical SCI. Importantly, in SCI
and other types of CNS trauma, we do not understand
which forms of circuit re-connectivity are truly able to
promote recovery, which significantly limits our ability to
develop targeted therapies in an informed manner. This is
the case for respiratory function, but also for the other
circuits and functional outcomes affected by nervous system trauma. To address this critical circuit mechanism
issue, we show that PAP4 was able to promote robust
eNeuro.org
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levels of rVRG axon regeneration; when regeneration was
surgically ablated, recovery was completely lost, demonstrating that regeneration through the injury was responsible for driving functional improvement.
We observed differences in the degree of rVRG axon
regeneration across the ipsilateral PhMN pool (i.e., that
relatively little regeneration occurred into the more caudal
portions of the PhMN pool). These data may suggest that,
while the observed rVRG axon regeneration and synaptic
reconnectivity with PhMNs is exciting, this mode of circuit
plasticity may actually not be the mechanism underlying
functional recovery induced by PAP4. Furthermore, this
mechanism may be at play, but only for the recovery of
ventral diaphragm function given the significantly greater
rVRG axon regeneration occurring at the most rostral
PhMN pool locations. Serotonergic axon growth may instead be the plasticity mode operating across the PhMN
pool to drive recovery at all three diaphragm subregions
given that we observed equivalent levels of 5-HT axon
synaptic innervation of PhMNs at all three caudal distances from the lesion. It is also possible that both rVRG
and serotonergic axon plasticity is contributing to functional recovery, but that the relative contribution of each
may vary significantly across the PhMN pool.
In addition to observing relatively low amounts of rVRG
axon regeneration caudally past C3, we also did not
achieve robust levels of synaptic reinnervation of PhMNs
by rVRG axons, even at C3 where we observed the greatest amount of regeneration. This further suggests that
rVRG axon regeneration may not be playing a role in
functional recovery at medial and dorsal diaphragm subregions and may only be playing a partial role at the
ventral subregion (or may not even be involved here as
well). Although we did not promote a large amount of
monosynaptic connectivity between regenerating rVRG
axons and PhMNs, it is possible that these regenerating
rVRG axons still contributed to functional recovery,
including at all three muscle subregions. Re-lesion completely ablated PAP-induced EMG recovery, demonstrating that regeneration (of some axon population) through
the lesion was responsible for driving recovery and suggesting that rVRG axons were at least partially involved in
this effect. As we found relatively low amounts of rVRG
axon regeneration caudally past C3, it is possible that the
regenerating rVRG axons that reached the C3 spinal cord
innervated intrasegmental and intersegmental interneuron
populations that allow these regrowing rVRG axons to
also mediate inspiratory activation of more caudallylocated PhMNs in the C4 –C5 spinal cord via circuits that
are not restricted to rVRG-PhMN monosynaptic connection. Cervical SCI induces plasticity of rVRG connections
with pre-phrenic cervical interneurons (Lane et al., 2008b).
In future studies, it will be important to assess synaptic
input of ipsilateral-originating rVRG axons and contralateral-originating rVRG axons onto spinal pre-phrenic
interneurons to determine whether PTEN manipulation
promoted recovery beyond just mono-synaptic circuitry.
Given the important role of descending serotonergic
input in modulating PhMN excitability (Dale-Nagle et al.,
2010), enhanced 5-HT fiber growth (alone or in combinaSeptember/October 2019, 6(5) ENEURO.0096-19.2019
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tion with rVRG axon regeneration) may have been the
mechanism underlying respiratory recovery. To this notion, we found that PAP4 increased 5-HT fiber density in
the C3–C5 ventral horn caudal to C2 hemisection around
the PhMN pool; we also found that PAP4 significantly
enhanced putative synaptic connections of these serotonergic axons specifically with PhMNs. We found serotonergic axons within the lesion site in both DMSO-control
and PAP4 animals (data not shown), suggesting that the
re-lesion could have resulted in the loss of diaphragm
functional recovery by severing these regrowing 5-HT
axons (and not by damaging the regenerating rVRG axons; or a combination of both). However, the degree of
putative synaptic innervation of CTB-labeled PhMNs by
5-HT axons (shown in Fig. 7K–O) was equal across the
entire PhMN pool, suggesting that this serotonergic axon
input to the PhMNs on the side of SCI was not due to
regeneration of serotonergic axons through the lesion but
instead was due to local growth of axons spared by the
hemisection already present at these various C3–C5 locations. Otherwise, we would expect to find the greatest
degree of serotonergic axon-PhMN synaptic connection
at C3 (i.e., the most rostral site closest to the injury), with
decreasing levels of serotonergic axon-PhMN connections at farther caudal distances (i.e., similar to pattern of
rVRG axon counts at C3–C5 shown in Fig. 5B). To further
address this issue, in future work we will use chemogenetic approaches (e.g., DREADDs; Roth, 2016) to selectively silence ipsilateral or contralateral rVRG neurons or
serotonergic raphe neurons to more definitively determine
which neuronal population(s) underlie functional recovery
in response to PAP4 and other interventions.
Given that PTEN manipulation has previously been
shown to promote sprouting of other neuron populations
such as corticospinal tract axons (Liu et al., 2010), it is
interesting that PAP4 did not stimulate contralateral rVRG
sprouting in the ipsilateral ventral horn in our study. As
one explanation, it is possible that uninjured contralateral
rVRG neurons have insufficient PTEN activity levels after
SCI to limit a sprouting response and therefore PAP4
would be unable to further induce a response from these
spared axons. While our data do not show morphologic
effects of PAP4 on sprouting of these fibers within the
PhMN pool ipsilateral to the hemisection, they may still be
playing a role in the effects of PAP4 by, for example,
altering synaptic connections between these rVRG axons
and PhMNs via very short-distance sprouting that we
cannot appreciate with our analysis. We have not experimentally addressed this issue; therefore, future studies
will be necessary to further explore the contribution of
spared rVRG input to the actions of PAP4.
Although PTEN is thought of primarily in the context of
CNS injury as a neuronal-intrinsic inhibitor of axonal
growth potential (Park et al., 2010), PAP4 may have stimulated rVRG axon regeneration through a non-cell autonomous mechanism. For example, PAP4 may have altered
properties of the glial and/or fibrotic scar (Goncalves
et al., 2015; Chen et al., 2016) such that cellular components of these scar structures produced increased progrowth factors or had reduced synthesis of inhibitory
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molecules. While we did not observe any quantitative
difference in overall morphology of the astrocyte scar (i.e.,
size of the scar), it is not possible to examine every
possible effect and therefore completely rule this out. We
did find that PAP4 increased signaling along the mTOR
axis specifically in rVRG neurons, supporting that the
effect of PAP4 on rVRG axon plasticity was at least in part
due to an increase in neuronal-intrinsic axon growth potential. We also performed immunohistochemistry on medulla and cervical spinal cord by double-labeling for pS6K
and the astrocyte lineage marker GFAP; we found no
effect of PAP4 on pS6K levels in astrocytes in-or-around
the lesion site or in the rVRG (data not shown), suggesting
that PAP4 was acting through a more direct effect on
neurons (although more thorough analysis would be required to more strongly substantiate such a claim). We
also previously showed using a biotintylated version of
PAP that the antagonist peptide does get into neurons
following injection into SCI rats (Ohtake et al., 2014).
Although we have not performed the same analysis again
in the current study, our previous work suggests that
PAP4 does get into rVRG neurons and that PAP4 is
exerting its effect at least in part directly on rVRG neurons.
While we have shown that PAP4 promoted significant
recovery of diaphragm function in vivo under eupnic
breathing conditions, there are limitations of our functional analysis. We conducted electrophysiological recordings (i.e., EMGs and CMAPs) to specifically assess
effects on diaphragm activation and PhMN-diaphragm
circuitry, although EMGs and CMAPs do not fully provide
evaluation of the physiologic effects on respiratory function. Importantly, we did not perform assessments of
overall ventilatory function such as whole-body plethysmography or blood gas measurements. In addition, we
did not conduct EMG recordings in response to hypercapnic and hypoxic challenges. To further examine the
functional effects of our PAP4 approach on respiratory
circuitry, in future work, we will need to test effects on
these additional functional outcomes and in response to
respiratory challenges.
In conclusion, we report that non-invasive systemic
delivery of a peptide that inhibits PTEN function results in
regeneration of rVRG axons that are critical to diaphragmatic respiratory function and that are damaged by cervical SCI. These regenerating rVRG axons extend along
the PhMN pool to synaptically reconnect with their appropriate targets. However, PAP4 did not stimulate sprouting
of axons originating in the contralateral rVRG or increased
synaptic input of these fibers to denervated PhMNs, suggesting that plasticity of spared rVRG axonal populations
was not responsible for driving improvement. In addition,
PAP4 resulted in significant 5-HT axon growth and
synaptic innervation of PhMNs caudal to the lesion, suggesting that plasticity of both rVRG and 5-HT axon populations may have acted in concert to drive recovery.
Finally, our findings demonstrate that axon regeneration
through the lesion is causally responsible for promoting
the robust degree of restoration of diaphragm function
induced by PAP4, although we did not conclusively determine the specific regenerating axon population(s) meSeptember/October 2019, 6(5) ENEURO.0096-19.2019
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diating this effect. This approach may have significant
therapeutic implications for treating persistent debilitating
respiratory dysfunction in individual affected by SCI.

References
Ahuja CS, Wilson JR, Nori S, Kotter MRN, Druschel C, Curt A,
Fehlings MG (2017) Traumatic spinal cord injury. Nat Rev Dis
Primers 3:17018.
Alilain WJ, Horn KP, Hu H, Dick TE, Silver J (2011) Functional
regeneration of respiratory pathways after spinal cord injury. Nature 475:196 –200.
Bezdudnaya T, Hormigo KM, Marchenko V, Lane MA (2018) Spontaneous respiratory plasticity following unilateral high cervical spinal cord injury in behaving rats. Exp Neurol 305:56 –65.
Boulenguez P, Gauthier P, Kastner A (2007) Respiratory neuron
subpopulations and pathways potentially involved in the reactivation of phrenic motoneurons after C2 hemisection. Brain Res
1148:96 –104.
Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN,
Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes
functional recovery after spinal cord injury. Nature 416:636 –640.
Charsar BA, Urban MW, Lepore AC (2017) Harnessing the power of
cell transplantation to target respiratory dysfunction following spinal cord injury. Exp Neurol 287:268 –275.
Chen CH, Sung CS, Huang SY, Feng CW, Hung HC, Yang SN, Chen
NF, Tai MH, Wen ZH, Chen WF (2016) The role of the PI3K/Akt/
mTOR pathway in glial scar formation following spinal cord injury.
Exp Neurol 278:27–41.
Dale-Nagle EA, Hoffman MS, MacFarlane PM, Satriotomo I, LovettBarr MR, Vinit S, Mitchell GS (2010) Spinal plasticity following
intermittent hypoxia: implications for spinal injury. Ann NY Acad
Sci 1198:252–259.
Dobbins EG, Feldman JL (1994) Brainstem network controlling descending drive to phrenic motoneurons in rat. J Comp Neurol
347:64 –86.
Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV (2004) Reactive astrocytes protect tissue and preserve
function after spinal cord injury. J Neurosci 24:2143–2155.
Geoffroy CG, Lorenzana AO, Kwan JP, Lin K, Ghassemi O, Ma A, Xu
N, Creger D, Liu K, He Z, Zheng B (2015) Effects of PTEN and
Nogo codeletion on corticospinal axon sprouting and regeneration
in mice. J Neurosci 35:6413–6428.
Geoffroy CG, Hilton BJ, Tetzlaff W, Zheng B (2016) Evidence for an
age-dependent decline in axon regeneration in the adult mammalian central nervous system. Cell Rep 15:238 –246.
Ghosh B, Wang Z, Nong J, Urban MW, Zhang Z, Trovillion VA, Wright
MC, Zhong Y, Lepore AC (2018) Local BDNF delivery to the injured
cervical spinal cord using an engineered hydrogel enhances diaphragmatic respiratory function. J Neurosci 38:5982–5995.
Giger RJ, Hollis ER 2nd, Tuszynski MH (2010) Guidance molecules in
axon regeneration. Cold Spring Harb Perspect Biol 2:a001867.
Goncalves MB, Malmqvist T, Clarke E, Hubens CJ, Grist J, Hobbs C,
Trigo D, Risling M, Angeria M, Damberg P, Carlstedt TP, Corcoran
JP (2015) Neuronal RAR␤ signaling modulates PTEN activity directly in neurons and via exosome transfer in astrocytes to prevent
glial scar formation and induce spinal cord regeneration. J Neurosci 35:15731–15745.
Goshgarian HG, Ellenberger HH, Feldman JL (1991) Decussation of
bulbospinal respiratory axons at the level of the phrenic nuclei in
adult rats: a possible substrate for the crossed phrenic phenomenon. Exp Neurol 111:135–139.
Huebner EA, Strittmatter SM (2009) Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ 48:339 –
351.
Issa AN, Zhan WZ, Sieck GC, Mantilla CB (2010) Neuregulin-1 at
synapses on phrenic motoneurons. J Comp Neurol 518:4213–
4225.
eNeuro.org

New Research
Kanno H, Ozawa H, Sekiguchi A, Yamaya S, Tateda S, Yahata K, Itoi
E (2012) The role of mTOR signaling pathway in spinal cord injury.
Cell Cycle 11:3175–3179.
Kinkead R, Zhan WZ, Prakash YS, Bach KB, Sieck GC, Mitchell GS
(1998) Cervical dorsal rhizotomy enhances serotonergic innervation of phrenic motoneurons and serotonin-dependent long-term
facilitation of respiratory motor output in rats. J Neurosci 18:8436 –
8443.
Lane MA, Fuller DD, White TE, Reier PJ (2008a) Respiratory neuroplasticity and cervical spinal cord injury: translational perspectives.
Trends Neurosci 31:538 –547.
Lane MA, White TE, Coutts MA, Jones AL, Sandhu MS, Bloom DC,
Bolser DC, Yates BJ, Fuller DD, Reier PJ (2008b) Cervical prephrenic interneurons in the normal and lesioned spinal cord of the adult
rat. J Comp Neurol 511:692–709.
Lane MA, Lee KZ, Fuller DD, Reier PJ (2009) Spinal circuitry and
respiratory recovery following spinal cord injury. Respir Physiol
Neurobiol 169:123–132.
Laskowski MB, Sanes JR (1987) Topographic mapping of motor
pools onto skeletal muscles. J Neurosci 7:252–260.
Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD,
Maragakis NJ (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease.
Nat Neurosci 11:1294 –1301.
Lepore AC, Tolmie C, O’Donnell J, Wright MC, Dejea C, Rauck B,
Hoke A, Ignagni AR, Onders RP, Maragakis NJ (2010) Peripheral
hyperstimulation alters site of disease onset and course in SOD1
rats. Neurobiol Dis 39:252–264.
Lewandowski G, Steward O (2014) AAVshRNA-mediated suppression of PTEN in adult rats in combination with salmon fibrin
administration enables regenerative growth of corticospinal axons
and enhances recovery of voluntary motor function after cervical
spinal cord injury. J Neurosci 34:9951–9962.
Li K, Nicaise C, Sannie D, Hala TJ, Javed E, Parker JL, Putatunda R,
Regan KA, Suain V, Brion JP, Rhoderick F, Wright MC, Poulsen
DJ, Lepore AC (2014) Overexpression of the astrocyte glutamate
transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury. J Neurosci 34:7622–
7638.
Li K, Javed E, Hala TJ, Sannie D, Regan KA, Maragakis NJ, Wright
MC, Poulsen DJ, Lepore AC (2015a) Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves
diaphragm function following cervical SCI. Mol Ther 23:533–548.
Li K, Javed E, Scura D, Hala TJ, Seetharam S, Falnikar A, Richard JP,
Chorath A, Maragakis NJ, Wright MC, Lepore AC (2015b) Human
iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury. Exp Neurol 271:479 –492.
Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I,
Tedeschi A, Park KK, Jin D, Cai B, Xu B, Connolly L, Steward O,
Zheng B, He Z (2010) PTEN deletion enhances the regenerative
ability of adult corticospinal neurons. Nat Neurosci 13:1075–1081.
Liu X, Williams PR, He Z (2015) SOCS3: a common target for
neuronal protection and axon regeneration after spinal cord injury.
Exp Neurol 263:364 –367.
Luo X, Park KK (2012) Neuron-intrinsic inhibitors of axon regeneration: PTEN and SOCS3. Int Rev Neurobiol 105:141–173.
Mantilla CB, Bailey JP, Zhan WZ, Sieck GC (2012) Phrenic motoneuron expression of serotonergic and glutamatergic receptors following upper cervical spinal cord injury. Exp Neurol 234:191–199.
Mantilla CB, Seven YB, Hurtado-Palomino JN, Zhan WZ, Sieck GC
(2011) Chronic assessment of diaphragm muscle EMG activity
across motor behaviors. Respir Physiol Neurobiol 177:176 –182.
Mitchell GS, Sloan HE, Jiang C, Miletic V, Hayashi F, Lipski J (1992)
5-Hydroxytryptophan (5-HTP) augments spontaneous and evoked
phrenic motoneuron discharge in spinalized rats. Neurosci Lett
141:75–78.
Nicaise C, Hala TJ, Frank DM, Parker JL, Authelet M, Leroy K, Brion
JP, Wright MC, Lepore AC (2012) Phrenic motor neuron degener-

September/October 2019, 6(5) ENEURO.0096-19.2019

19 of 19

ation compromises phrenic axonal circuitry and diaphragm activity
in a unilateral cervical contusion model of spinal cord injury. Exp
Neurol 235:539 –552.
Nicaise C, Frank DM, Hala TJ, Authelet M, Pochet R, Adriaens D,
Brion JP, Wright MC, Lepore AC (2013) Early phrenic motor neuron
loss and transient respiratory abnormalities after unilateral cervical
spinal cord contusion. J Neurotrauma 30:1092–1099.
Ohtake Y, Park D, Abdul-Muneer PM, Li H, Xu B, Sharma K, Smith
GM, Selzer ME, Li S (2014) The effect of systemic PTEN antagonist
peptides on axon growth and functional recovery after spinal cord
injury. Biomaterials 35:4610 –4626.
Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L,
Kramvis I, Sahin M, He Z (2008) Promoting axon regeneration in
the adult CNS by modulation of the PTEN/mTOR pathway. Science 322:963–966.
Park KK, Liu K, Hu Y, Kanter JL, He Z (2010) PTEN/mTOR and axon
regeneration. Exp Neurol 223:45–50.
Perrier JF, Rasmussen HB, Christensen RK, Petersen AV (2013)
Modulation of the intrinsic properties of motoneurons by serotonin. Curr Pharm Des 19:4371–4384.
Roth BL (2016) DREADDs for neuroscientists. Neuron 89:683–694.
Silver J, Schwab ME, Popovich PG (2015) Central nervous system
regenerative failure: role of oligodendrocytes, astrocytes, and microglia. Cold Spring Harb Perspect Biol 7:a020602.
Steinmetz MP, Horn KP, Tom VJ, Miller JH, Busch SA, Nair D, Silver
DJ, Silver J (2005) Chronic enhancement of the intrinsic growth
capacity of sensory neurons combined with the degradation of
inhibitory proteoglycans allows functional regeneration of sensory
axons through the dorsal root entry zone in the mammalian spinal
cord. J Neurosci 25:8066 –8076.
Sun F, Park KK, Belin S, Wang D, Lu T, Chen G, Zhang K, Yeung C,
Feng G, Yankner BA, He Z (2011) Sustained axon regeneration
induced by co-deletion of PTEN and SOCS3. Nature 480:372–375.
Urban MW, Ghosh B, Strojny LR, Block CG, Blazejewski SM, Wright
MC, Smith GM, Lepore AC (2018) Cell-type specific expression of
constitutively-active Rheb promotes regeneration of bulbospinal
respiratory axons following cervical SCI. Exp Neurol 303:108 –119.
Warren PM, Alilain WJ (2014) The challenges of respiratory motor
system recovery following cervical spinal cord injury. Prog Brain
Res 212:173–220.
Warren PM, Awad BI, Alilain WJ (2014) Drawing breath without the
command of effectors: the control of respiration following spinal
cord injury. Respir Physiol Neurobiol 203:98 –108.
Willenberg R, Zukor K, Liu K, He Z, Steward O (2016) Variable
laterality of corticospinal tract axons that regenerate after spinal
cord injury as a result of PTEN deletion or knock-down. J Comp
Neurol 524:2654 –2676.
Wright MC, Son YJ (2007) Ciliary neurotrophic factor is not required
for terminal sprouting and compensatory reinnervation of neuromuscular synapses: re-evaluation of CNTF null mice. Exp Neurol
205:437–448.
Wright MC, Cho WJ, Son YJ (2007) Distinct patterns of motor nerve
terminal sprouting induced by ciliary neurotrophic factor vs. botulinum toxin. J Comp Neurol 504:1–16.
Wright MC, Mi R, Connor E, Reed N, Vyas A, Alspalter M, Coppola G,
Geschwind DH, Brushart TM, Höke A (2014) Novel roles for osteopontin and clusterin in peripheral motor and sensory axon
regeneration. J Neurosci 34:1689 –1700.
Ylera B, Ertürk A, Hellal F, Nadrigny F, Hurtado A, Tahirovic S,
Oudega M, Kirchhoff F, Bradke F (2009) Chronically CNS-injured
adult sensory neurons gain regenerative competence upon a lesion of their peripheral axon. Curr Biol 19:930 –936.
Zhou SY, Basura GJ, Goshgarian HG (2001) Serotonin(2) receptors
mediate respiratory recovery after cervical spinal cord hemisection
in adult rats. J Appl Physiol (1985) 91:2665–2673.
Zukor K, Belin S, Wang C, Keelan N, Wang X, He Z (2013) Short
hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J Neurosci 33:
15350 –15361.

eNeuro.org

